News

Genome of Dangerous Pathogen Deciphered in 15-year Study of COPD Patients

A 15-year study demonstrated how nontypeable Haemophilus influenzae (NTHi), one of the most important pathogens in chronic obstructive pulmonary disease (COPD), adapts and survives in patients’ airways over time. The research findings were reported in the journal Proceedings of the National Academy of Sciences, in a study titled “…

Long-term Aspirin Use Reduces Severity of Acute COPD Exacerbations, Study Reports

The long-term use of aspirin was found to reduce the severity of acute exacerbations in chronic obstructive pulmonary disease (AECOPD), including in-hospital mortality, invasive ventilation use, and hospital length-of-stay (LOS), researchers reported. The study, “The association of aspirin use with severity of acute exacerbation of chronic obstructive pulmonary disease:…

Ultibro Breezhaler Improved Cardiac Function in COPD Patients with Lung Hyperinflation

Novartis’ Ultibro Breezhaler provided noteworthy improvements in cardiac and lung function in chronic obstructive pulmonary disease (COPD) patients with lung hyperinflation (overinflated lungs) when compared to placebo, a new research study found. The study reporting the findings, “Effect of lung deflation with indacaterol plus glycopyrronium on ventricular…